Jing Xu
Heilongjiang University of Chinese Medicine(CN)First People's Hospital of Yunnan Province(CN)
Publications by Year
Research Areas
Neurological Disease Mechanisms and Treatments, Parkinson's Disease Mechanisms and Treatments, Retinal Diseases and Treatments, Autophagy in Disease and Therapy, COVID-19 Clinical Research Studies
Most-Cited Works
- → Liraglutide improves cognitive impairment via the AMPK and PI3K/Akt signaling pathways in type 2 diabetic rats(2018)72 cited
- → The Mechanisms of Traditional Chinese Medicine Underlying the Prevention and Treatment of Parkinson's Disease(2017)44 cited
- → Systems pharmacology to investigate the interaction of berberine and other drugs in treating polycystic ovary syndrome(2016)38 cited
- → Dl‐3‐n‐butylphthalide promotes synaptic plasticity by activating the Akt/ERK signaling pathway and reduces the blood–brain barrier leakage by inhibiting the HIF‐1α/MMP signaling pathway in vascular dementia model mice(2023)22 cited
- → Inhibiting Roles of Berberine in Gut Movement of Rodents are Related to Activation of the Endogenous Opioid System(2013)21 cited
- → Neuroprotection of Triptolide against Amyloid-Beta1-42-induced toxicity via the Akt/mTOR/p70S6K-mediated Autophagy Pathway(2022)18 cited